Microtomes operate on
different technologies, including manual, semi-automated, and fully automated.
Manual microtomes segment accounted for the largest market share in 2018.
Manual microtomes are cost-effective and are easier to use as compared to
automatic and semi-automatic modules. These factors are supporting their
adoption in the market, and the trend is anticipated to continue over the
forecast period.
The report Microtome Market is
expected to grow from USD 129 million in 2019 to reach USD 177 million by 2024,
at a CAGR of 6.5%.
Download PDF Brochure:-https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=230495411
Clinical laboratories
and hospital laboratories are the main end-users of microtomes, among others.
In 2018, the hospital laboratories segment accounted for the largest market
share and was expected to grow at the highest CAGR during the forecast period.
The large share of the hospital laboratories segment is attributed to the
increasing number of patient visits to hospitals, rising number of in-house
clinical diagnostic procedures performed in hospitals, growing awareness
regarding early diagnosis, and the availability of reimbursements in developed
markets for clinical tests performed in hospitals.
By region, the
microtomes market is segmented into North America, Europe, Asia Pacific, and
the Rest of the World (RoW). In 2018, North America accounted for the largest
market share, followed by Europe.
The prominent players
operating in the microtomes market include Thermo Fisher Scientific (US),
Danaher Corporation (US), Sakura Finetek (Japan), SLEE Medical GmbH (Germany),
MEDITE GmbH (Germany), Histo-Line Laboratories (Italy), Amos Scientific (Australia),
RMC Boeckeler (US), Diapath S.p.A. (Italy), and Jinhua YIDI Medical Appliance
(China).
No comments:
Post a Comment